Fig 1.
Flow Chart of study participants.
TP only: Participants with T. pallidum DNA only; HD only: H. ducreyi DNA only; TP/HD: T. pallidum and H. ducreyi DNA co-infection; Negative: participants who were negative for DNA of both T. pallidum and H. ducreyi.
Table 1.
Demographic and clinical characteristics of study participants.
Fig 2.
Assessment of treatment outcomes following a single-dose oral Azithromycin for ulcers caused by T. pallidum (A): before treatment and (B): post treatment; H. ducreyi (C): pretreatment and (D): post treatment; T. pallidum and H. ducreyi coinfection (E): pretreatment and (F): post treatment; Negative for T. pallidum and H. ducreyi (G): pretreatment and (H) post treatment.
All post treatment assessments were undertaken 4 weeks after administration of single dose oral azithromycin.
Table 2.
Demographic and clinical characteristics of participants completely healed at follow-up.
Table 3.
Demographic and clinical characteristics of participants not completely healed at follow-up.
Table 4.
Clinical healing rates of H. ducreyi, T. pallidum, and PCR negative, DPP positive yaws ulcers at 4 weeks post-treatment.
Fig 3.
Kaplan-Meier estimate of healing probability over time by organism detection status.